セルソース(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4880/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/01/21 | 日証協 | 1,246,056株 | -8.82% | 234,101株 | -66.66% | 1,037,354株 | -5.75% | 118,090株 | -31.59% |
2022/01/14 | 日証協 | 1,366,519株 | +4.57% | 702,220株 | -8.76% | 1,100,600株 | +1.45% | 172,624株 | +41.81% |
2022/01/07 | 日証協 | 1,306,788株 | +59.71% | 769,679株 | +2.97% | 1,084,847株 | +40.83% | 121,732株 | -68.62% |
2021/12/30 | 日証協 | 818,220株 | 0% | 747,505株 | 0% | 770,331株 | 0% | 387,951株 | 0% |
2021/12/24 | 日証協 | 818,220株 | +28.92% | 747,505株 | +52.88% | 770,331株 | +13.6% | 387,951株 | +11.26% |
2021/12/17 | 日証協 | 634,697株 | +67.94% | 488,964株 | +141.7% | 678,096株 | +49.51% | 348,690株 | +97.73% |
2021/12/10 | 日証協 | 377,924株 | +28.89% | 202,306株 | +120.63% | 453,560株 | +15.58% | 176,343株 | +403.31% |
2021/12/03 | 日証協 | 293,225株 | +5.52% | 91,696株 | -28.08% | 392,424株 | +1.14% | 35,037株 | -60.77% |
2021/11/26 | 日証協 | 277,879株 | +0.97% | 127,489株 | -45.86% | 387,983株 | -0.41% | 89,301株 | -63.07% |
2021/11/19 | 日証協 | 275,204株 | -5.42% | 235,478株 | -69.3% | 389,585株 | +10.91% | 241,815株 | -25.4% |
2021/11/05 | 日証協 | 265,485株 | +81.95% | 175,649株 | +15.58% | 360,214株 | +281.36% | 110,847株 | -29.49% |
2021/10/29 | 日証協 | 145,909株 | +83.39% | 151,977株 | +2475.88% | 94,454株 | -19.82% | 157,201株 | +2394.86% |
2021/10/22 | 日証協 | 79,563株 | -0.71% | 5,900株 | -77.18% | 117,799株 | +2.05% | 6,301株 | -52.17% |
2021/10/15 | 日証協 | 80,135株 | -4.56% | 25,860株 | +54.96% | 115,430株 | -0.8% | 13,174株 | +80.64% |
2021/10/08 | 日証協 | 83,963株 | +0.1% | 16,688株 | +456.27% | 116,359株 | +1.3% | 7,293株 | -27.88% |
2021/10/01 | 日証協 | 83,881株 | -1.96% | 3,000株 | -87.18% | 114,866株 | -3.26% | 10,112株 | +62.83% |
2021/09/24 | 日証協 | 85,557株 | -5.31% | 23,406株 | -52.92% | 118,742株 | +0.18% | 6,210株 | -76.84% |
2021/09/17 | 日証協 | 90,357株 | -23.85% | 49,711株 | -0.4% | 118,533株 | -16.95% | 26,812株 | +44.83% |
2021/09/10 | 日証協 | 118,661株 | -1.63% | 49,910株 | +6.45% | 142,725株 | -3.12% | 18,513株 | -4.08% |
※株式分割は考慮していませんのでご注意ください。
Page Top